STOCK TITAN

TNL Mediagene (TNMWF) SEC Filings

TNMWF OTC
Rhea-AI Summary

TNL Mediagene regained compliance with Nasdaq’s Equity Rule, which requires a minimum of $2,500,000 in stockholders’ equity. Nasdaq said its determination followed review of the company’s October 30, 2026 Form 6-K concerning the completed sale of its Japanese operating subsidiaries, together with supplemental pro forma financial information.

A Mandatory Panel Monitor applies for 1 year from November 16, 2026. If Nasdaq staff finds the company again out of compliance during that period, staff will issue a Delist Determination Letter; the company may not submit a compliance plan, receive additional time, or be afforded an applicable cure period, but may request a new hearing.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

TNL Mediagene’s ordinary shares are reported as 0.00 shares beneficially owned by each reporting person, The Goldman Sachs Group, Inc. and Goldman Sachs & Co. LLC, with each reporting 0.0% of the class. Each also lists 0.00 sole and shared voting and dispositive power. A note says the Goldman Sachs reporting units disclaim beneficial ownership of securities in certain client accounts and investment entities, subject to the conditions described in the ownership information.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
-
Rhea-AI Summary

TNL Mediagene (TNMG) completed a $6.25 million investment from Vector Advisory Partners LLC on October 30, 2026, issuing Series A and Series B convertible preferred shares. Vector paid $1.5 million at signing and $4.75 million at closing, including direct payments to holders of certain outstanding convertible notes and transaction service providers. At Vector’s direction, 938,257 Series A and 2,816,647 Series B shares were issued to designees Ka Lun To and Chi Ching Hung in approximately equal proportions. Remaining proceeds after payoffs and approved transaction expenses will be retained as permanent equity and working capital, including an initial operating-transition reserve of at least $750,000 unless Vector otherwise approves; up to $800,000 may be designated after closing for an issuer-repurchase reserve, subject to further board approval and applicable legal and Nasdaq requirements.

Before required shareholder, Nasdaq, Cayman Islands and other approvals, Series A represents approximately 19.99% of fully diluted ordinary shares on an as-converted basis; Series B cannot convert until applicable approvals are obtained and effective. Following approvals, the preferred shares are expected to represent approximately 80% on that basis, resulting in a change of control. Shing Hei Lee, Vector’s designee, was appointed a director effective at closing; the board has five directors.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
Rhea-AI Summary

TNL Mediagene (TNMG) completed the sale of all issued and outstanding shares of its Japanese holding company to MI Company on October 30, 2026, for aggregate consideration of $5.5 million. At closing, MI Company paid or satisfied the purchase price with approximately $3.85 million in cash, approximately $0.15 million through set-off of net intercompany debt liabilities, and $1.5 million through assumption, discharge, cancellation or other extinguishment of indebtedness under Company promissory notes. Consideration is subject to adjustment based on changes in net intercompany debt liabilities from $612,064 as of July 31, 2026, and to set-off; the aggregate amount of adjustments and set-off is capped at $500,000.

The holding company held, directly or indirectly, Mediagene Inc. and Infobahn Inc. MI Company was formed as the acquisition vehicle for an investor group led by Motoko Imada, TNMG’s former CEO and director. A special committee of disinterested, independent directors reviewed and negotiated the sale, and the board approved it on the committee’s recommendation. At closing, Imada and Hiroto Kobayashi resigned from the board; Imada, CFO Hiroyuki Terao and Chief Governance Officer Aya Miyake also resigned from their positions. TNMG continues to operate in Taiwan and believes stockholders’ equity exceeds Nasdaq’s $2.5 million minimum, stating it has demonstrated compliance.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

TNL Mediagene entered into an agreement for Vector Advisory Partners LLC to purchase newly authorized Series A and Series B convertible preferred shares for an aggregate purchase price of $6.25 million. Vector paid a $1.5 million signing payment, credited dollar-for-dollar against the purchase price; the remaining $4.75 million is due at closing. The company expects to use proceeds for approved debt repayments and transaction expenses, retaining the balance as permanent equity and working capital. This includes an initial operating-transition reserve of at least $750,000 unless Vector otherwise approves; up to $800,000 may be designated after closing for an issuer-repurchase reserve, subject to further board approval and applicable legal and Nasdaq requirements.

At closing, the company expects to issue approximately 938,257 Series A and 2,816,647 Series B preferred shares, each with an original issue price of approximately $1.66449 per share. Before required shareholder, Nasdaq, Cayman Islands and other approvals, Series A is expected to represent approximately 19.99% of fully diluted ordinary shares on an as-converted basis; Series B cannot convert until applicable approvals are obtained and effective. Following those approvals, both series are expected to represent approximately 80%, resulting in a change of control. No ordinary shares will be issued at closing; closing is expected no later than the tenth calendar day following the agreement’s effective date, subject to specified conditions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

TNL Mediagene (TNMG) regained compliance with Nasdaq’s minimum bid price requirement, Nasdaq confirmed in a letter dated October 14, 2026. Under the Nasdaq Hearings Panel’s August 23, 2026 decision, the company’s ordinary shares will continue to be listed and traded on The Nasdaq Capital Market during an exception period, subject to the decision’s terms.

The company remains non-compliant with Nasdaq’s stockholders’ equity requirement, which requires at least $2.5 million in stockholders’ equity. TNL Mediagene must demonstrate compliance on or before October 30, 2026, and the Panel will review any compliance submission. The company intends to take all steps necessary to meet the requirement by that deadline, but there can be no assurance it will do so. If it fails to demonstrate compliance by the deadline or otherwise fails to satisfy the decision’s terms, its securities will be subject to delisting from Nasdaq.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
Form 6-K
Rhea-AI Summary

TNL Mediagene (symbol: TNMG) is the issuer of record for a Form 6-K filing submitted to the SEC.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

TNL Mediagene (TNMG) has approved and is implementing a 1-for-8 share consolidationSeptember 8, 2026 under the same ticker, with a new CUSIP.

Every eight issued and outstanding ordinary shares will be combined into one, with no fractional shares issued and any fractions rounded up to the nearest whole share. This will reduce the number of outstanding ordinary shares from 6,084,581 to approximately 760,573, based on shares outstanding as of September 2, 2026. The consolidation is intended to increase the trading price of the shares to assist in regaining compliance with Nasdaq’s $1.00 minimum bid price requirement and to potentially broaden institutional investor interest. Related warrants, equity awards and other equity instruments will have their exercise or conversion prices adjusted proportionally.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.00%
Tags
current report
-
Rhea-AI Summary

TNL Mediagene (TNMG) reports that the Nasdaq Hearings Panel has granted its request for continued listing on The Nasdaq Capital Market, subject to meeting specified conditions during an exception period. The decision follows an August 4, 2026 hearing where the company presented a plan to regain compliance with Nasdaq’s Bid Price Rule and Equity Rule.

The company’s ordinary shares will continue trading under symbol TNMG while it works to regain and maintain compliance, and it must promptly notify Nasdaq of any significant events affecting its status. The Panel may reconsider the exception if circumstances change, and TNL Mediagene cautions that there is no assurance it will satisfy the conditions; failure would result in delisting of its securities from Nasdaq.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.00%
Tags
current report
Rhea-AI Summary

TNL Mediagene reported that its Board of Directors has formed a special committee of independent directors to lead an evaluation of potential strategic transactions and alternatives. The committee consists of Priscilla Han (Chair), Lauren Zalaznick, and Naoko Okumoto.

The special committee is authorized to review, evaluate and, as appropriate, negotiate and make recommendations on options that may include a financing, recapitalization, merger, business combination, share issuance, disposition, or continuing the current operations. It has engaged Greenberg Traurig, LLP as independent legal counsel and Imperial Capital, LLC as independent financial advisor, with Imperial Capital tasked to identify and evaluate transactions aimed at maximizing shareholder value. Management will continue operating the business and support the process when requested. No definitive course of action has been determined, and there is no assurance that any transaction will occur.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
18.18%
Tags
current report

FAQ

How many TNL Mediagene (TNMWF) SEC filings are available on StockTitan?

StockTitan tracks 21 SEC filings for TNL Mediagene (TNMWF), including 20-F annual reports and 6-K reports. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for TNL Mediagene (TNMWF)?

The most recent SEC filing for TNL Mediagene (TNMWF) was filed on November 18, 2026.